₹604.85
▲ +9.76 +1.64%
17 Jul 2026
NSE Listed · Pharmaceuticals
ASM 1Unichem Laboratories Ltd. (UNICHEMLAB)
Volume: 7,482Avg Vol 1W: 1,75,014Avg Vol 1M: 7,81,14452W Range:₹278.2₹687.2
Key Ratios
Checked just nowMarket Cap₹4,258 Cr
Current Price₹604.85
Previous Close₹595.09
High / Low (52w)₹687.2 / ₹278.2
Volume7,482
Avg Vol (1W)1,75,014
Avg Vol (1M)7,81,144
Stock P/E52.01
Book Value₹385.97
Dividend Yield0%
ROE288.06%
ROA6.77%
Revenue (TTM)—
Revenue Growth18.25%
Profit Margin11.48%
Total Debt₹61 Cr
Shares Outstanding7 Cr
Face Value₹2
EPS (TTM)₹11.63
P/B1.57
Debt / Equity0.19
50 DMA₹495.98
200 DMA₹385.73
Day change+1.64%
SurveillanceASM 1 (as of 2026-07-17)
Price Chart
₹604.85▲ 29.68% · 1Y
2025-11-212026-07-16
20-day avg volume: 8.6L shares
Pros
- Healthy return on equity of 288.1%.
- Company is almost debt-free.
- Net profit is growing year over year.
Cons
- Stock trades at a high P/E of 52.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹483 Cr | ₹507 Cr | ₹533 Cr | ₹587 Cr | ₹527 Cr | ₹579 Cr | ₹521 Cr | ₹575 Cr |
| EBITDA | ₹12 Cr | ₹32 Cr | ₹69 Cr | ₹63 Cr | ₹-2 Cr | ₹56 Cr | ₹25 Cr | ₹41 Cr |
| Net Profit | ₹2 Cr | ₹25 Cr | ₹58 Cr | ₹53 Cr | ₹-10 Cr | ₹-12 Cr | ₹264 Cr | ₹11 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,278 Cr | ₹1,195 Cr | ₹1,285 Cr | ₹1,317 Cr | ₹1,382 Cr | ₹1,817 Cr | ₹2,146 Cr | ₹2,265 Cr |
| EBITDA | ₹-52 Cr | ₹-41 Cr | ₹57 Cr | ₹29 Cr | ₹-120 Cr | ₹-5 Cr | ₹176 Cr | ₹122 Cr |
| Net Profit | ₹-24 Cr | ₹-60 Cr | ₹34 Cr | ₹33 Cr | ₹-202 Cr | ₹-94 Cr | ₹138 Cr | ₹253 Cr |
| EPS | -3.38 | -8.55 | 4.88 | 4.68 | -28.72 | -13.32 | 19.47 | 35.85 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹3,150 Cr | ₹3,145 Cr | ₹3,126 Cr | ₹3,319 Cr | ₹3,193 Cr | ₹3,275 Cr | ₹3,569 Cr | ₹3,737 Cr |
| Total Liabilities | ₹530 Cr | ₹613 Cr | ₹569 Cr | ₹700 Cr | ₹758 Cr | ₹837 Cr | ₹1,119 Cr | ₹1,020 Cr |
| Equity | ₹2,620 Cr | ₹2,531 Cr | ₹2,557 Cr | ₹2,618 Cr | ₹2,435 Cr | ₹2,438 Cr | ₹2,451 Cr | ₹2,717 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹-316 Cr | ₹24 Cr | ₹47 Cr | ₹-252 Cr | ₹-73 Cr | ₹20 Cr | ₹9 Cr | ₹11 Cr |
| Investing | ₹-286 Cr | ₹-36 Cr | ₹-74 Cr | ₹102 Cr | ₹203 Cr | ₹50 Cr | ₹-241 Cr | ₹192 Cr |
| Financing | ₹-2 Cr | ₹-62 Cr | ₹-121 Cr | ₹191 Cr | ₹-81 Cr | ₹-106 Cr | ₹184 Cr | ₹2 Cr |
| Free Cash Flow | ₹-316 Cr | ₹24 Cr | ₹47 Cr | ₹-252 Cr | ₹-73 Cr | ₹20 Cr | ₹9 Cr | ₹11 Cr |
Shareholding
Promoter 70.22% Institutions 11.36% Public 18.42%
Efficiency & Working Capital
ROCE3.8%
Interest Coverage4
Dividend Payout—
Debtor Days137 d
Inventory Days162 d
Payable Days59 d
Cash Conversion Cycle240 d
Working Capital Days299 d
Shareholding Details
As of 2026-06-30
Promoter70.2%
FII0.9%
DII10.5%
Institutions11.4%
Public18.4%
Promoter Pledge0%
No. of Shareholders25,347
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 70.2% | 70.2% | 70.2% | 70.2% | 70.2% | 70.2% | 70.2% | 70.2% | 70.2% | 70.2% | 70.2% | 70.2% |
| FIIs | 0.8% | 0.8% | 0.9% | 0.9% | 0.9% | 1.1% | 1% | 1% | 1% | 1% | 1% | 0.9% |
| DIIs | 10.3% | 10.8% | 11.3% | 11.6% | 11.7% | 11.6% | 11.3% | 10.9% | 10.7% | 10.7% | 10.6% | 10.5% |
| Public | 18.6% | 18.2% | 17.6% | 17.3% | 17.2% | 17.1% | 17.5% | 17.9% | 18% | 18% | 18.1% | 18.4% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 21,584 | 20,877 | 21,171 | 20,621 | 20,374 | 21,472 | 21,621 | 23,010 | 23,577 | 23,267 | 23,386 | 25,347 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Ipca Laboratories Limited | Shareholding of Promoter and Promoter Group | 52.7% | 3.71 Cr |
| Dr. Prakash Amrut Mody | Shareholding of Promoter and Promoter Group | 12.8% | 89,97,952 |
| Hdfc Small Cap Fund | Public Shareholding | 7.8% | 54,58,645 |
| Anita Prakash Mody | Shareholding of Promoter and Promoter Group | 1.9% | 13,23,400 |
| Dsp Healthcare Fund | Public Shareholding | 1.6% | 11,00,697 |
| Suparna Prakash Mody | Shareholding of Promoter and Promoter Group | 1.4% | 9,49,936 |
| Supriya Prakash Mody | Shareholding of Promoter and Promoter Group | 1.4% | 9,49,936 |
| Dr. Prakash Amrut Mody - Suparna Mody Trust (promoter Trust ) | Shareholding of Promoter and Promoter Group | 0.1% | 52,016 |
| Dr. Prakash Amrut Mody - Supriya Mody Trust (promoter Trust) | Shareholding of Promoter and Promoter Group | 0.1% | 45,052 |
| Dr. Prakash Amrut Mody - Shwetambari Mody Trust (promoter Trust) | Shareholding of Promoter and Promoter Group | 0.1% | 41,283 |
| The Hongkong And Shanghai Banking Corp.ltd. | Public Shareholding | 0% | 500 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Dr. Prakash Amrut Mody | 0 | 0% | 2026-06-30 |
| Anita Prakash Mody | 0 | 0% | 2026-06-30 |
| Suparna Prakash Mody | 0 | 0% | 2026-06-30 |
| Supriya Prakash Mody | 0 | 0% | 2026-06-30 |
| Dr. Prakash Amrut Mody - Suparna Mody Trust (promoter Trust ) | 0 | 0% | 2026-06-30 |
| Dr. Prakash Amrut Mody - Supriya Mody Trust (promoter Trust) | 0 | 0% | 2026-06-30 |
| Dr. Prakash Amrut Mody - Shwetambari Mody Trust (promoter Trust) | 0 | 0% | 2026-06-30 |
| Ipca Laboratories Limited | 0 | 0% | 2026-06-30 |
| Hdfc Small Cap Fund | 0 | 0% | 2026-06-30 |
| Dsp Healthcare Fund | 0 | 0% | 2026-06-30 |
| The Hongkong And Shanghai Banking Corp.ltd. | 0 | 0% | 2026-06-30 |
| Dr. Prakash Amrut Mody | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Prakash A Mody | Chairman(Non Exe)&Dir(Non-Ind) | 2026 |
| Pabitra Bhattacharya | Managing Director & CEO | 2026 |
| Pranay Godha | Non-Exec & Non-Independent Dir | 2026 |
| Anand T Kusre | Independent Non Exe. Director | 2026 |
| Arun Todarwal | Independent Non Exe. Director | 2026 |
| Swati Patankar | Independent Non Exe. Director | 2026 |
| Pradeep Bhandari | HEAD - LEGAL / CS / CHIEF COMPLIANCE OFFICER | 2026 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceuticals | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Domestic | ₹33 Cr | 2.4% |
| Americas | ₹916 Cr | 66.9% |
| Europe | ₹301 Cr | 22% |
| Africa | ₹52 Cr | 3.8% |
| Asia | ₹58 Cr | 4.3% |
| CIS | ₹9 Cr | 0.7% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹2 | 35 | 14 | 14 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 2,612 | 0 | 0 | 7 | 33 | 2,651 |
| 2026 | 488 | 0 | 0 | 0 | 0 | 488 |
| 2026 | 481 | 0 | 0 | 7 | 20 | 507 |
Insider / Designated-Person Trades
30 recent disclosure(s)
JATIN RAMANLAL MEHTADisposal · 13,200
GERARD MAJELLA COLEDisposal · 4,646
RAJARAM PAIDisposal · 4,000
IPCA LABORATORIES LIMITEDAcquisition · 1,35,79,571
VANDANA PANDEYDisposal · 6,000
DILIP KUNKOLIENKARDisposal · 5,000
Substantial Acquisitions (SAST)
2 disclosure(s)
Open Offer21/09/2023 · 1,35,79,571
Market10/01/2022 · 54,850
Company Information
🌐 www.unichemlabs.com ↗
📍 47 Kandivli Industrial Estate, Kandivli (West), Mumbai, Maharashtra, 400067
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
UltraTech CementUltramarine & Pigments LimitedUma Converter LimitedUma Exports LimitedUsha Martin Edu & Sol Ltd.Umiya Buildcon LimitedUnited Drilling Tools Ltd.Unicommerce eSolutions LimitedUniphos Enterprises Ltd.Unihealth Hospitals Ltd.UNIINFO Telecom Servi Ltd.Unilex Colours and Chem LimitedAll “U” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search